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Abstract: Accidentally ingested corrosive substances can cause functional and structural damage to the esoph-
ageal tissue resulting in stricture formation. It has been reported that the administration of olmesartan (OLM) 
can have anti-inflammatory, antifibrotic and antiapoptotic effects on injured tissue. The aim of our study was to 
check if OLM could prevent formation of scars in the corrosive esophageal burn model. Fifty-one Wistar Albino 
rats were divided into six groups: Control, Sham, OLM, Sham + OLM, Burn, and Burn + OLM. Olmesartan (5 
mg/kg) was given by gavage once per day for 21 consecutive days after injury. The morphology of the esophagus 
was assessed after Masson trichrome staining, and apoptosis was evaluated using the terminal deoxynucleotidyl 
transferased UTP nick end labeling (TUNEL) method. The serum nucleosomes (as an indicator of apoptosis), 
serum p53 protein, and esophageal tissue p53 protein levels of each group were measured by immunoassays. 
Muscularis mucosa damage, submucosal collagen deposition, and tunica muscularis injury in the Burn + OLM 
group decreased significantly compared with the Burn group (p < 0.05). Similarly, the number of apoptotic cells 
in the Burn + OLM group decreased compared with the Burn group (p < 0.05). Serum levels of nucleosomes and 
p53 and tissue of p53 protein did not differ between the groups. Exogenously administered OLM can effectively 
prevent the occurrence of esophageal strictures caused by corrosive esophageal burns. (Folia Histochemica et 
Cytobiologica 2014, Vol. 52, No. 1, 29–35)
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Introduction
Caustic esophageal burns in both children and adults 
remain an important cause of morbidity and morta-
lity around the world [1]. The burns can occur in the 
mouth and larynx and can cause extreme damage 
to the organs, resulting in loss of voice, difficulty in 
swallowing, and airway obstruction [1]. Long-term 
complications include the deposition of collagen 
and stricture formation. The latter can also increase 
gastroesophageal reflux and predispose to esophageal 
carcinoma [2]. Thus, one of the most important goals 
in treating of corrosive esophageal burns is to prevent 
the stricture formation. Several types of nonsurgical 
stricture techniques have been proposed, including 
dilatation, esophageal stent placement, total paren-
teral nutrition, steroids, and antibiotic therapy [1, 2]. 
30 Murat Dereli et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2014
10.5603/FHC.2014.0003
www.fhc.viamedica.pl
However, none of these treatment modalities seems 
to be effective in the treatment of severe caustic eso-
phageal burns [1, 2].
Angiotensin II and its receptor type 1 (AT1R) 
together with its downstream mediators are involved 
in immune and inflammatory responses and they 
can contribute to the generation of oxidative stress, 
regulation of cell growth and cell death and promotion 
of tissue remodeling. Inhibition of AT1R signaling 
can attenuate cellular stress and provide beneficial 
effects to the injured tissue [3, 4]. Olmesartan (OLM) 
is AT1R antagonist. In diabetic rat model of liver 
fibrosis OLM was found to be the most protective 
among tested AT1R blockers [5]. However, the ef-
fects of OLM on esophageal tissue regeneration and 
fibrosis after corrosive esophageal burns have yet not 
been studied.
Therefore, the aim of our study was to evaluate 
the effects of OLM on wound healing and stricture 
formation in the rat esophagus after caustic injury.
Material and methods
Animals and experimental protocol. The Trakya University 
guidelines for the care and use of laboratory animals were 
followed, and ethical committee consent was obtained for 
the study. Fifty-one female Wistar Albino rats weighing 
200–250 g each were randomly assigned to six groups: Con-
trol (n = 6), Sham (n = 8), OLM (n = 8), Sham + OLM 
(n = 8), Burn (n = 12), and Burn + OLM (n = 9). The rats 
in Sham and Sham + OLM groups underwent esophageal 
dissection only, while the rats in Burn and Burn + OLM 
groups underwent both esophageal dissection and experi-
mental esophageal burn formation. 
The rats were anesthetized with ketamine and xylazine 
administered i.p. (50 mg/kg and 10 mg/kg, respectively). Cau-
stic esophageal injury was produced using the Liu and Ri-
chardson [6] modification of the experimental model of Ge-
hanno and Guedon [7]. Briefly, after a median laparotomy, 
a 1.5-cm segment of the distal esophagus was exposed, and 
an 8 Fr feeding catheter with an outer diameter of 0.22 cm 
was placed into the distal esophagus via the oral route. 
A similar catheter was placed into the distal esophagus via 
gastrotomy. The catheters were secured, and an isolated 
segment of the distal esophagus was obtained. The distal 
catheter was clamped, and the isolated segment was disten-
ded by infusion of 25% NaOH at an intraluminal pressure 
of 10 cm H2O for two minutes, until a slight translucency of 
the esophageal wall and branching of the vessels were noted. 
Following this procedure, the distal catheter was unclamped, 
and the esophagus was rinsed with 40 mL of distilled water. 
The gastrotomy and laparotomy were subsequently closed.
Immediately after the formation of the esophageal burn 
in the Burn + OLM group, the administration of OLM 
(5 mg/kg daily) through gavage began and was continued for 
21 days. A similar OLM treatment was applied to the OLM 
and Sham + OLM groups. After the surgery, all animals 
were kept on a standard rodent pellet diet with tap water ad 
libitum, and 10 mL of 0.9% NaCl was administered subcuta-
neously for the first three postoperative days. Twenty one 
days after the initial treatment, rats were anesthetized and 
blood was collected for biochemical assays. The esophagus 
was opened longitudinally, and the injured area was removed 
and divided into two pieces. One sample was fixed in 4% 
neutral-buffered formaldehyde solution, whereas the other 
sample was kept at –80°C until further biochemical analyses. 
All the rats were subsequently euthanized with a high dose 
of phenobarbital.
Assessment of esophageal tissue. Esophageal tissues were 
examined under a light microscope at the Trakya University 
Faculty of Medicine, Histology and Embryology Depart-
ment’s Light Microscopic Laboratory. For this purpose, the 
esophageal tissues were fixed for four days in neutral-buff-
ered 10% formalin solution. Then, tissues were washed for 
two days in 70% alcohol and processed into paraffin blocks 
using a standard procedure. Using a Leica RM-2245 micro-
tome, 6 µm thick sections were stained using the Masson 
trichrome method. The deposition of submucosal collagen 
in the esophageal wall and muscular mucosa and the depth 
of the injury were assessed and scored semi-quantitatively 
as described previously [8].
Evaluation of apoptotic cells by the TUNEL method. The 
apoptosis of the fibroblasts of esophageal submucosa was 
evaluated using the terminal deoxynucleotidyl transferased 
UTP nick end labeling (TUNEL) technique [9]. The 6 µm 
thick sections were placed in the oven at 37°C overnight, 
and afterwards were thoroughly cleared of paraffin and 
rehydrated in decreasing concentrations of ethanol. There-
after, sections were incubated at room temperature for 
15 minutes in proteinase K solution (20 mg/mL, Cat. no. 
21627, Chemicon International, Temecula, CA, USA). The 
sections were washed with distilled water, and then in the 
solution of methanol in 3% H2O2 for five minutes to block 
the endogenous peroxidase activity. Later, the sections were 
incubated with the terminal deoxynucleotidyl transferase 
enzyme (Cat. no. S7100, Chemicon) in the oven at 37°C for 
one hour. The anti-digoxigenin sections were also washed 
with PBS three times for 10 minutes. Diaminobenzidine 
dissolved in PBS was applied at room temperature for 
30 minutes. The sections were washed again in distilled water 
for ten minutes, and methyl green staining was performed. 
The sections were then dehydrated with toluol for 2–3 min-
utes, cover-slipped, and evaluated by light microscopy. To 
count the TUNEL-positive cells in the esophageal tissue, 
the ocular micrometer compatible with an Olympus BX51 
microscope was used. TUNEL-positive cells were counted 
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under a 100-square ocular micrometer (eye piece graticule; 
eyepiece ×10, objective ×40). In each section, the num-
ber of cells in ten diﬀerent, randomly selected areas were 
counted, and the arithmetic mean was calculated. For the 
×40 magniﬁcation, the 100-square micrometer area was 
determined by means of a micrometer slide. Finally, all 
counts were expressed as the number of TUNEL-positive 
cells per unit area (mm2).
Determination of nucleosome concentration in the serum. 
The serum nucleosomes level (mono- and oligonucleosomes 
as indicators of apoptosis) was determined using the ELISA 
kit (Cat. no. 11774425001; Roche, Maharashtra, India), 
according to the manufacturer’s instructions. 
Determination of p53 protein contents in esophageal tissue 
and the serum. Prior to biochemical measurements, the 
esophageal tissue samples were weighted and added to 
10-fold quantity of cold potassium phosphate buffer (pH 7.4) 
and homogenized using a glass homogenizer at 4°C. The 
homogenates were centrifuged at 10.000 rpm at 4°C, and 
the supernatants were separated. The concentrations of p53 
protein in esophageal tissue homogenates and in the serum 
were assessed using the ELISA kit (Cat. no. 11828789001; 
Roche Molecular Biochemicals, Mannheim, Germany) 
according to the manufacturer’s instructions. 
Statistical analysis. The data was analyzed using a commer-
cially available statistical software package (SPSS 15.0, SPSS 
Inc., Chicago, IL, USA). The normal distribution of the va-
riables was tested using a one-sample Kolmogorov-Smirnov 
test. For variables with normal distribution, the differences 
among the groups were compared using one-way ANOVA 
followed by the Bonferroni post-hoc test if a significant 
difference was found. The Kruskal-Wallis test was used for 
non-normal distributed data. Dual comparisons between 
the groups that were significantly different were evaluated 
using the Mann-Whitney U test. The results are presented 
as means ± SEM, and p values less than 0.05 were regarded 
as statistically significant.
Results
Assessment of esophageal tissue stained  
by Masson trichrome method
Changes that occurred in the esophageal tissue after 
the corrosive esophageal burns were examined accor-
ding to the criteria and scores shown in Table 1. In 
the Burn group the muscular layer exhibited a higher 
number of fibroblasts, increased collagen deposition 
between muscle bundles and reduced thickness as 
compared with the intact esophagus of control group 
(Figure 1B and 1A, respectively). However, in the 
Burn + OLM group collagen fiber deposition and 
number of fibroblast between muscle cells were re-
duced as compared with the Burn group (Figure 1C 
and 1B, respectively). The results of semiquantitative 
histopathologic evaluation of esophageal tissues 
showed that the submucosal collagen deposition, 
muscularis mucosa damage, and tunica muscularis 
damage scores of the Burn + OLM group were found 
to be significantly lower than those of the Burn group 
(p < 0.005, p < 0.005, and p < 0.002, respectively; 
Table 2). 
Assessment of apoptosis in the esophageal tissue
The results of the TUNEL staining of fibroblasts in the 
submucosa of esophageal wall are shown in Table 3 
and Figure 2. The average number of apoptotic cells 
was significantly reduced in the Burn + OLM group 
as compared to the Burn group (p < 0.005; Table 2). 
At the same time, the average number of apoptotic 
cells in the Burn and Burn + OLM groups were higher 
than in the other groups (Control, Sham, OLM, and 
Sham + OLM; p < 0.002 and p < 0.003, respectively; 
Table 2). 
Biochemical measurements
The serum concentrations of nucleosomes and p53 
protein as well as the contents of p53 protein in eso-
phageal tissue were similar in all experimental groups 
and did not differ significantly (Table 4). 
Table 1. Histopathological evaluation criteria and scores of 
esophageal damage according to Türkyilmaz et al. [11]
Criteria Score 
Increased submucosal collagen deposition
None 0
Mild (submucosal collagen at least twice  
the thickness of the muscularis mucosa)
1 + 
Marked (submucosal collagen more than twice 
the thickness of the muscularis mucosa)
2 + 
Presence of injury in the muscularis mucosa 
None 0
Present 1 +
Presence of injury and collagen deposition  
in the tunica muscularis
None 0 
Mild (collagen deposition around myocytes) 1 + 
Marked (same as mild, with collagen deposition 
replacing some myocytes)
2 + 
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Table 3. The number of apoptotic cells in esophageal tissues of the studied groups
Control Sham OLM S+OLM Burn Burn+OLM
3.32±0.75 3.64±0.90 3.82±0.70 3.50±1.38 56.17±0.90*# 31.22±1.17†
Apoptosis was assessed by the TUNEL method as described in Methods. Values are expressed as mean ± SD. Description of groups as for Table 2.  
*significantly different from Control, Sham, OLM and S+OLM groups, p < 0.002; # p < 0.005 compared with Burn+OLM; † significantly differ-
ent from Control, Sham, OLM and S+OLM groups, p < 0.003
Figure 1. Histologic appearance of esophagus stained by Masson trichrome method. A. Normal esophagus (control 
group), ×200; B. Burn group: in the muscle layer an increased number of fibroblasts is seen (arrows) and the thickness of 
the muscularis mucosa (arrowheads) is reduced, ×400; C. Burn + OLM group: the reduction of connective tissue (arrows) 
in the muscle layer of esophageal wall is clearly visible, as well as reduced number of fibroblasts, ×400. Symbols: E — 
epithelium; SM — submucosa; TM —  tunica muscularis
Table 2. Semiquantitative histopathologic evaluation of esophageal tisues based on Masson trichrome staining
Control Sham OLM S+OLM Burn Burn+OLM
Submucosal collegen deposition 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 1.58±0.19* 0.78±022
Muscularis mucosa injury 0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 1.00±0.00* 0.44±0.18
Tunica muscularis injury and  
collagen deposition
0.00±0.00 0.00±0.00 0.00±0.00 0.00±0.00 1.67±0.14** 0.56±0.24
Total score 4.25 ± 0.33**  1.89± 0.51
Description of groups as in Methods. Values are expressed as mean ± SD, scores were obtained according to the criteria presented in Table 1. 
*, **significantly different from Burn+OLM group, p<0.005 and p<0.002, respectively.
Figure 2. Presence of apoptotic cells in esophageal tissue visualized by TUNEL method. A. Control rat, lack of apoptotic 
cells; B. Burn group: increased number of TUNEL-positive cells; C. Burn + OLM group: lower number of TUNEL posi-
tive cells as compared with the Burn group. Symbols: arrows, TUNEL positive cells. ×400 
A B C
A B C
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Esophageal burn caused by corrosive substances 
initially leads to acute necrosis and thrombosis with 
consequent ischemia and hypoxia, which are followed 
by the inflammation and oxidative stress [1, 2]. Pro-
longed stressful conditions are caused by the release 
of proinflammatory cytokines (and growth factors) 
as well as the exposure to reactive oxygen species 
(ROS). Both can result in an excessive activation and 
proliferation of fibroblasts but also in increased rate 
of cell death [3, 10]. By the second and third week 
after the caustic injury, collagen deposition begins 
and fibrosis followed by stricture formation may 
occur [2]. It is well documented that after the cell 
injury, the renin-angiotensin system, particularly the 
signaling mediated by angiotensin II receptor type 
I, is essential for the activation of NADPH oxidase, 
stimulates secretion of pro-inflammatory and profi-
brotic cytokines and exerts a direct mitogenic effect 
on fibroblasts [3, 4]. Thus, we decided to investigate 
the putative influence of treatment with olmesartan, 
an AT1R blocker, on fibrosis and apoptosis in the rat 
model of esophageal caustic burn. The administration 
of OLM started immediately after the injury and was 
continued during the next 21 days, including second 
and third week of tissue repair, i.e. recovery period 
during which collagen deposition and formation of 
strictures occur. 
The results of the present study provide the first 
demonstration that the treatment with OLM can ef-
fectively prevent fibrosis and limit the damage to the 
esophageal tissue in the animal model of caustic burn. 
We also demonstrated that administration of OLM 
can reduce proliferation of fibroblasts and deposition 
of collagen induced by the injury. Moreover, we found 
that OLM can have anti-apoptotic properties and signi-
ficantly limit injury-evoked apoptosis in the esophagus.
In recent years several experimental studies have 
shown that OLM-mediated AT1R inhibition can 
provide beneficial effects in respect to the excessive 
collagen deposition which leads to fibrosis and tissue 
remodeling. OLM was found to inhibit peritoneal 
fibrosis and loss of mesothelium in a laboratory 
model of hypertensive rats subjected to continuous 
peritoneal dialysis [11]. Inhibition of AT1R in a rat 
model of nonalcoholic steatohepatitis resulted in 
a significant reduction of the activation of stellate 
(Ito) cells, oxidative stress and the expression of liver 
fibrosis-related genes: transforming growth factor-b1 
(TGF-b1) and collagen genes [12]. OLM was also 
successfully tested as a potential antifibrotic drug in 
another experimental model of liver fibrosis [13]. It 
was shown that the inhibition of AT1R suppressed 
the proliferation of stellate cells, collagen synthesis 
and expression of profibrogenic cytokines such as 
TGF-b1 and connective tissue growth factor (CTGF) 
by activated stellate cells. AT1R antagonism appeared 
to attenuate collagen synthesis, fibrosis and structur-
al remodeling in rabbit model of atrial fibrillation 
and it was proposed that OLM acted through the 
inhibition of p38MAPK/ERK pathway in cardiac 
fibroblasts [14]. Furthermore, in the canine model of 
atrial fibrillation, interstitial fibrosis was caused by the 
AT1R-dependent up-regulation of strong mediator of 
ECM synthesis, CTGF, and this effect was partially 
abolished by OLM [15]. 
The anti-fibrotic properties of OLM cannot be 
dissociated from its anti-apoptotic and anti-necrotic 
effects which play a protective role in injured tissues. 
For instance, OLM administered after a myocardial 
infarction attenuated injury-evoked up-regulation of 
BAX protein, Fas receptor and Fas ligand [16]. Sim-
ilarly, the induction of TNF-a expression in the rat 
model of steatohepatitis was limited by the inhibition 
of AT1R signaling by OLM [15]. In a study of exper-
imental autoimmune myocarditis OLM prevented 
apoptosis by decreasing the levels of mediators of 
oxidative stress, endoplasmic reticulum stress, and 
cardiac inflammatory mediators [17]. It was also 
documented that anti-apoptotic action of OLM in 
perivascular injury and hepatic steatosis can be me-
diated by inhibition of the apoptosis signal regulating 
kinase 1 (ASK1) [18].
The presented study is the first one which de-
monstrated anti-apoptotic effect of OLM on injured 
Table 4. The concentrations of nucleosomes and p53 and tissue level of p53 protein in esophageal tissue
Sham OLM S+OLM Burn Burn+OLM
Serum nucleosomes (mU/ml) 7.17±3.64 3.43±0.59 2.45±0.32 4.68±0.96 24.93±15.57
p53 tissue content (pg/g wet tissue) 3008.3±481.5 3829.8±1104.8 2446.0±438.5 2821.9±594.5 2028.6±571.4
p53 serum level (pg/ml) 47.84±10.46 96.01±32.87 42.18±14.21 156.54±61.91 40.88±15.70
Description of groups as for Table 2. Serum concentration of nucleosomes and p53 protein as well as p53 protein content in tissues were measured 
as described in Methods. Values are expressed as mean ± SD. There were no statistically significant differences between groups, p > 0.05
34 Murat Dereli et al.
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2014
10.5603/FHC.2014.0003
www.fhc.viamedica.pl
esophageal tissue. The number of TUNEL-positive 
apoptotic cells decreased in the esophagus of OLM
-treated animals, however, the levels of the p53 prote-
in were similar between the experimental groups. The 
local tissue injury did not affect serum levels of p53 
protein and nucleosomes in the OLM-treated animals. 
It was documented that the activation of p53 protein 
(and its downstream proteins) in cultured myocytes 
correlated with the activation of renin-angiotensin 
system mediated by AT1R [19]. The ability of p53 pro-
tein to bind DNA and induce apoptosis in these cells 
was abolished by the treatment with AT1R blocker, 
losartan [19]. Thus, the pro-apoptotic action of p53 is 
mediated rather by changes in its activity and binding 
properties than quantity. Moreover, the p53 protein 
has a very short half-life period (several minutes) [20]. 
These two facts can explain why we did not find any 
differences between experimental groups in the tissue 
and serum levels of the p53 protein.
Tissue-protective effects of OLM were demon-
strated in studies carried out on rats subjected to 
subtotal nephrectomy. Morphological and functional 
symptoms of progressive renal injury induced in these 
rats were alleviated by the inhibition of AT1R [21, 22, 
23]. Similarly, the treatment with OLM significantly 
attenuated the number of TUNEL-positive cells in 
the animal model of progressive glomerular injury 
[23] and in the kidneys of hypertensive rats [24]. Mo-
reover, in both cited studies, OLM-reduced apoptosis 
was associated with lower degree of interstitial fibrosis 
or glomerular sclerosis, respectively. Authors of the 
above-mentioned studies suggested that beneficial 
role of OLM was associated rather with its antioxi-
dant properties than antihypertensive action on renal 
cardiovascular system. The latter suggests that the 
anti-fibrotic and anti-apoptotic effects of OLM admi-
nistration in esophageal caustic burn observed in our 
study could be also attributed to the suppression of 
oxidative stress by AT1R antagonism. This hypothesis 
is in agreement with the results of previous studies 
which demonstrated partially successful treatment 
of caustic esophageal burns by increasing the antioxi-
dant capacity of the tissue [25–35]. The present study 
provides new evidence that the renin-angiotensin 
system can be a promising target for the treatment of 
esophageal burns caused by corrosive agents. 
In conclusion, our results confirm that administra-
tion of OLM can reduce pro-fibrotic and pro-apop-
totic stimuli evoked by caustic esophageal burn. Based 
on the results of ours and other studies we demon-
strate that the treatment with OLM can have direct 
impact on the formation of stenosis in esophageal 
caustic burn, possibly due to anti-inflammatory and 
antioxidant properties of OLM. Further studies are 
needed to unravel the mechanisms of anti-fibrotic and 
anti-apoptotic action of OLM in the esophageal tissue. 
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